Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Weekly and Every 3 Week Administration of Paclitaxel Liposome Injection in Metastatic Breast Cancer

NCT02142790 is registered in ClinicalTrials.gov with Nanjing Luye Sike Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT02142790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02142790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Weekly and Every 3 Week Administration of Paclitaxel Liposome Injection in Metastatic Breast Cancer
Lead sponsor
Nanjing Luye Sike Pharmaceutical Co., Ltd.
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2014
Completion date
Not reported
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer